Click to view dynamic map
Talks will include:
1) OCT biomarkers in DMO - what adds value in clinical-decision making? - Christiana Dinah, Consultant Ophthalmologist and medical retina specialist, London
2) Debate: When should you switch treatment in DMO? versus late - Deepali Varma, Consultant Ophthalmologist and medical retina specialist, Sunderland & Phil Burgess, Consultant Ophthalmologist and medical retina specialist, Liverpool